Predictions
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year
Mullen Group Ltd.
Start price
Target price
Perf. (%)
€10.00
03.01.23
03.01.23
€14.00
03.01.24
03.01.24
-7.50%
20.12.23
20.12.23
Sernova Corp.
Start price
Target price
Perf. (%)
€0.53
30.12.22
30.12.22
€5.00
30.12.25
30.12.25
-10.84%
15.12.23
15.12.23
Could be very worthwhile Investment >20% year
Endeavour Silver Corp.
Start price
Target price
Perf. (%)
€3.15
28.12.22
28.12.22
-
28.01.26
28.01.26
-45.12%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
IAMGOLD Corp.
Start price
Target price
Perf. (%)
€2.32
27.12.22
27.12.22
-
27.12.23
27.12.23
-7.49%
24.02.23
24.02.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Oceanagold Corp.
Start price
Target price
Perf. (%)
€1.85
27.12.22
27.12.22
-
27.12.23
27.12.23
-10.47%
13.10.23
13.10.23
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Magna International Inc.
Start price
Target price
Perf. (%)
€51.12
22.12.22
22.12.22
-
22.12.23
22.12.23
1.68%
24.08.23
24.08.23
American Lithium Corp
Start price
Target price
Perf. (%)
€2.07
22.12.22
22.12.22
€4.00
22.01.23
22.01.23
39.73%
23.01.23
23.01.23
High Investments for future growth
Capable Management
Good culture
Stable Large shareholder and/or long term investor
Mandalay Resources Corp.
Start price
Target price
Perf. (%)
€1.94
14.12.22
14.12.22
-
14.12.23
14.12.23
-34.02%
15.12.23
15.12.23
Could be worthwhile Investment >10% per year
Energy Fuels Inc.
Start price
Target price
Perf. (%)
€5.78
13.12.22
13.12.22
-
13.12.23
13.12.23
8.44%
11.01.23
11.01.23
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Pan American Silver Corp.
Start price
Target price
Perf. (%)
€15.76
09.12.22
09.12.22
-
09.12.23
09.12.23
-11.84%
10.12.23
10.12.23
Agnico Eagle Mines Ltd
Start price
Target price
Perf. (%)
€49.08
09.12.22
09.12.22
-
09.12.23
09.12.23
-3.48%
10.12.23
10.12.23
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.64
09.12.22
09.12.22
-
09.12.23
09.12.23
-6.42%
10.12.23
10.12.23
Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€1.14
08.12.22
08.12.22
€1.60
08.12.23
08.12.23
-59.94%
22.07.23
22.07.23
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€5.87
28.11.22
28.11.22
€5.00
28.11.23
28.11.23
-46.39%
29.11.23
29.11.23
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
ROE lower than 10% per year
American Lithium Corp
Start price
Target price
Perf. (%)
€1.41
26.11.22
26.11.22
€1.00
26.11.23
26.11.23
101.84%
11.01.23
11.01.23
EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
negative Cash Flow expected
Windfall Geotek Inc.
Start price
Target price
Perf. (%)
€0.039
25.11.22
25.11.22
-
25.11.25
25.11.25
-22.08%
24.10.23
24.10.23
Could be very worthwhile Investment >20% year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€1.32
21.11.22
21.11.22
€1.00
21.11.23
21.11.23
-65.91%
11.11.23
11.11.23
Could be very worthwhile Investment >20% year
Top 10 in its market
High valuation
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.58
21.11.22
21.11.22
-
21.11.23
21.11.23
-85.09%
22.11.23
22.11.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€1.33
21.11.22
21.11.22
-
21.11.23
21.11.23
-67.62%
22.11.23
22.11.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Innovative
Top 10 in its market
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
19.11.22
19.11.22
€2.00
19.11.23
19.11.23
-41.00%
20.11.23
20.11.23
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected